These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18604710)

  • 1. The mosaic of myeloid neoplasia: implications for classification.
    Steensma DP
    Leuk Lymphoma; 2008 Jul; 49(7):1228-9. PubMed ID: 18604710
    [No Abstract]   [Full Text] [Related]  

  • 2. The implications of revised WHO classification (2008) of chronic myeloid neoplasms.
    Găman M; Vlădăreanu AM; Radesi S
    Rom J Intern Med; 2011; 49(1):25-30. PubMed ID: 22026249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topics in pediatric leukemia--myelodysplastic and myeloproliferative disorders of childhood.
    Lasky J; Sakamoto KM
    MedGenMed; 2005 Mar; 7(1):21. PubMed ID: 16369326
    [No Abstract]   [Full Text] [Related]  

  • 4. Myelodysplastic syndromes: biologic and clinical aspects.
    Cazzola M; Riccardi A
    Haematologica; 1986; 71(2):147-59. PubMed ID: 3087837
    [No Abstract]   [Full Text] [Related]  

  • 5. Detangling fibrosis assessment in MPNs.
    Mesa RA
    Leuk Res; 2010 Jul; 34(7):854-5. PubMed ID: 20137811
    [No Abstract]   [Full Text] [Related]  

  • 6. Myeloproliferative neoplasms (MPNs).
    Godfrey AL
    Blood Rev; 2020 Jul; 42():100717. PubMed ID: 32527564
    [No Abstract]   [Full Text] [Related]  

  • 7. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification.
    Kvasnicka HM; Thiele J
    Pathobiology; 2007; 74(2):63-71. PubMed ID: 17587877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic and myeloproliferative disorders in children.
    Hasle H
    Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion of secondary chronic myelomonocytic leukemia and myeloproliferative disease, unclassifiable, in classification of pediatric myeloproliferative disorders.
    Occhipinti E; Correa H; Yu L; Craver R
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):700-1. PubMed ID: 17023836
    [No Abstract]   [Full Text] [Related]  

  • 10. Myeloproliferative neoplasms: Morphology and clinical practice.
    Barbui T; Thiele J; Vannucchi AM; Tefferi A
    Am J Hematol; 2016 Jun; 91(4):430-3. PubMed ID: 26718907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders.
    Thiele J; Kvasnicka HM
    Leuk Lymphoma; 2006 Mar; 47(3):381-96. PubMed ID: 16396760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of myeloproliferative disorders in the JAK2 era: is there a role for red cell mass?
    Cassinat B; Laguillier C; Gardin C; de Beco V; Burcheri S; Fenaux P; Chomienne C; Kiladjian JJ;
    Leukemia; 2008 Feb; 22(2):452-3. PubMed ID: 17713549
    [No Abstract]   [Full Text] [Related]  

  • 14. Modern diagnostics in chronic myeloproliferative diseases (CMPDs).
    Haferlach T; Kern W; Schnittger S; Schoch C
    Ann Hematol; 2004; 83 Suppl 1():S59-61. PubMed ID: 15124674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The WHO 2008 classification of Ph-myeloproliferative disorders: statement of the Czech MPD Working Group.
    Schwarz J; Penka M; Indrák K; Pospísilová D; Pytlík R; Dulícek P; Doubek M; Kren L; Campr V;
    Leukemia; 2008 Nov; 22(11):2118-9. PubMed ID: 18418405
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in understanding and management of myeloproliferative neoplasms.
    Vannucchi AM; Guglielmelli P; Tefferi A
    CA Cancer J Clin; 2009; 59(3):171-91. PubMed ID: 19369682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of histologic classification in nonfibrotic myeloproliferative neoplasia.
    Koopmans SM; Bot FJ; Lam KH; van Marion AM; de Raeve H; Hebeda KM
    Am J Clin Pathol; 2011 Oct; 136(4):618-24. PubMed ID: 21917685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of Philadelphia translocation-negative myeloproliferative neoplasms: its impact on data from clinical trials.
    Naresh KN
    J Clin Oncol; 2009 Nov; 27(31):e175-6; author reply e177-8. PubMed ID: 19704052
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone marrow histopathology in myeloproliferative disorders--current diagnostic approach.
    Thiele J; Kvasnicka HM; Orazi A
    Semin Hematol; 2005 Oct; 42(4):184-95. PubMed ID: 16210032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical myeloproliferative disorders: diagnosis and management.
    Tefferi A; Elliott MA; Pardanani A
    Mayo Clin Proc; 2006 Apr; 81(4):553-63. PubMed ID: 16610578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.